Risk Factors Contributing to Oral Cancer in Patients at Dr. Hasan Sadikin General Hospital Bandung
1 other identifier
observational
107
1 country
1
Brief Summary
Analytical research with a cross-sectional approach was carried out on patients diagnosed with oral cavity cancer who visited our outpatient clinic in Bandung between 2023 and 2024. Data were collected and analyzed using the chi-square test to determine the significance of the relationship between smoking, alcohol consumption, oral hygiene, and betel quid chewing and oral cavity cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2023
CompletedFirst Submitted
Initial submission to the registry
November 4, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 4, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 4, 2024
CompletedFirst Posted
Study publicly available on registry
November 15, 2024
CompletedNovember 15, 2024
November 1, 2024
1.8 years
November 4, 2024
November 13, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Risk factors for oral cavity cancer
Risk factors for oral cavity cancer will be listed
3 months
Study Arms (2)
Oral cavity cancer group
The inclusion criterion was a confirmed diagnosis of oral cavity cancer undergoing surgical intervention. Patients with oral cancer resulting from metastasis from a primary tumor located in another organ were excluded.
Control group
The control group consisted of individuals attending the hospital for non-cancer-related conditions matched by age and sex to the case group.
Eligibility Criteria
This study was conducted at the oncology, ENT, and oral surgery outpatient clinics of the hospital from January 2023 to December 2024.
You may qualify if:
- Confirmed diagnosis of oral cavity cancer undergoing surgical intervention.
You may not qualify if:
- Oral cancer resulting from metastasis from a primary tumor located in another organ
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universitas Padjajaran
Bandung, West Java, 40161, Indonesia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Agung Adhariensya, MD
Faculty of Medicine Universitas Padjadjaran
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 4, 2024
First Posted
November 15, 2024
Study Start
January 1, 2023
Primary Completion
November 4, 2024
Study Completion
November 4, 2024
Last Updated
November 15, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share